BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 17617379)

  • 1. Lethal factor of anthrax toxin binds monomeric form of protective antigen.
    Chvyrkova I; Zhang XC; Terzyan S
    Biochem Biophys Res Commun; 2007 Aug; 360(3):690-5. PubMed ID: 17617379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular dynamics simulations of complexes between wild-type and mutant anthrax protective antigen variants and a model anthrax toxin receptor.
    Stiles L; Nelson DJ
    J Biomol Struct Dyn; 2005 Apr; 22(5):503-19. PubMed ID: 15702923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of toxin functional domains in anthrax pathogenesis.
    Brossier F; Weber-Levy M; Mock M; Sirard JC
    Infect Immun; 2000 Apr; 68(4):1781-6. PubMed ID: 10722564
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anthrax toxin complexes: heptameric protective antigen can bind lethal factor and edema factor simultaneously.
    Pimental RA; Christensen KA; Krantz BA; Collier RJ
    Biochem Biophys Res Commun; 2004 Sep; 322(1):258-62. PubMed ID: 15313199
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Crystal structure of a complex between anthrax toxin and its host cell receptor.
    Santelli E; Bankston LA; Leppla SH; Liddington RC
    Nature; 2004 Aug; 430(7002):905-8. PubMed ID: 15243628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anthrax protective antigen (PA63) bound conformation of a peptide inhibitor of the binding of lethal factor to PA63: as determined by trNOESY NMR and molecular modeling.
    Hicks RP; Bhattacharjee AK; Koser BW; Traficante DD
    J Med Chem; 2004 Oct; 47(22):5347-55. PubMed ID: 15481973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.
    Mogridge J; Cunningham K; Lacy DB; Mourez M; Collier RJ
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7045-8. PubMed ID: 11997437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping the lethal factor and edema factor binding sites on oligomeric anthrax protective antigen.
    Cunningham K; Lacy DB; Mogridge J; Collier RJ
    Proc Natl Acad Sci U S A; 2002 May; 99(10):7049-53. PubMed ID: 11997439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oligomerization of anthrax toxin protective antigen and binding of lethal factor during endocytic uptake into mammalian cells.
    Singh Y; Klimpel KR; Goel S; Swain PK; Leppla SH
    Infect Immun; 1999 Apr; 67(4):1853-9. PubMed ID: 10085027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of membrane translocation by anthrax protective antigen.
    Wesche J; Elliott JL; Falnes PO; Olsnes S; Collier RJ
    Biochemistry; 1998 Nov; 37(45):15737-46. PubMed ID: 9843379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anthrax toxin.
    Bhatnagar R; Batra S
    Crit Rev Microbiol; 2001; 27(3):167-200. PubMed ID: 11596878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blocking anthrax lethal toxin at the protective antigen channel by using structure-inspired drug design.
    Karginov VA; Nestorovich EM; Moayeri M; Leppla SH; Bezrukov SM
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15075-80. PubMed ID: 16214885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of residues 147VYYEIGK153 in binding of lethal factor to protective antigen of Bacillus anthracis.
    Gupta P; Singh A; Chauhan V; Bhatnagar R
    Biochem Biophys Res Commun; 2001 Jan; 280(1):158-63. PubMed ID: 11162493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large-scale structural changes accompany binding of lethal factor to anthrax protective antigen: a cryo-electron microscopic study.
    Ren G; Quispe J; Leppla SH; Mitra AK
    Structure; 2004 Nov; 12(11):2059-66. PubMed ID: 15530370
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural determinants for the binding of anthrax lethal factor to oligomeric protective antigen.
    Melnyk RA; Hewitt KM; Lacy DB; Lin HC; Gessner CR; Li S; Woods VL; Collier RJ
    J Biol Chem; 2006 Jan; 281(3):1630-5. PubMed ID: 16293620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both PA63 and PA83 are endocytosed within an anthrax protective antigen mixed heptamer: a putative mechanism to overcome a furin deficiency.
    Chekanov AV; Remacle AG; Golubkov VS; Akatov VS; Sikora S; Savinov AY; Fugere M; Day R; Rozanov DV; Strongin AY
    Arch Biochem Biophys; 2006 Feb; 446(1):52-9. PubMed ID: 16384550
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A model of anthrax toxin lethal factor bound to protective antigen.
    Lacy DB; Lin HC; Melnyk RA; Schueler-Furman O; Reither L; Cunningham K; Baker D; Collier RJ
    Proc Natl Acad Sci U S A; 2005 Nov; 102(45):16409-14. PubMed ID: 16251269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purified Bacillus anthracis lethal toxin complex formed in vitro and during infection exhibits functional and biological activity.
    Panchal RG; Halverson KM; Ribot W; Lane D; Kenny T; Abshire TG; Ezzell JW; Hoover TA; Powell B; Little S; Kasianowicz JJ; Bavari S
    J Biol Chem; 2005 Mar; 280(11):10834-9. PubMed ID: 15644338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The channel formed in planar lipid bilayers by the protective antigen component of anthrax toxin.
    Finkelstein A
    Toxicology; 1994 Feb; 87(1-3):29-41. PubMed ID: 7512762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trp 346 and Leu 352 residues in protective antigen are required for the expression of anthrax lethal toxin activity.
    Batra S; Gupta P; Chauhan V; Singh A; Bhatnagar R
    Biochem Biophys Res Commun; 2001 Feb; 281(1):186-92. PubMed ID: 11178978
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.